DURBIN QUESTIONS WITNESSES DURING HEARING ON PRESCRIPTION DRUG PRICES, COMPETITION, AND INNOVATION

DURBIN PREVIEWS JUDICIARY COMMITTEE HEARING ON PRESCRIPTION DRUG PRICES, COMPETITION, AND INNOVATIONПодробнее

Durbin Questions Witnesses at Judic Subcommittee Hearing on Restoring Competition To Digital MarketsПодробнее

DURBIN DELIVERS OPENING STATEMENT DURING HEARING ON RX DRUG PRICES, COMPETITION, AND INNOVATIONПодробнее

DURBIN QUESTIONS WITNESSES AT SENATE JUDICIARY COMMITTEE HEARING ON REDUCING PRESCRIPTION DRUG COSTSПодробнее

Durbin Questions Witnesses During Subcommittee On Intellectual Property Hearing on Foreign ThreatsПодробнее

Senator Baldwin Questions Witnesses at a Hearing on the Rising Costs of Prescription DrugsПодробнее

Durbin: We Should Protect American Consumers from Outrageous Prices on Prescription DrugsПодробнее

SENATE JUDICIARY COMMITTEE HEARING IN CHICAGO ON REDUCING PRESCRIPTION DRUG COSTS OPENING STATEMENTПодробнее

Durbin presses for Increased Transparency and Competition to Lower Prescription Drug PricesПодробнее

Durbin Questions Witnesses at Hearing on Federal Crack and Powder Cocaine Sentencing DisparityПодробнее

Full Committee Hearing on Drug PricesПодробнее

Durbin Questions Witness During Judic Subcommittee Hearing on Artificial Intelligence & Human RightsПодробнее

Durbin Questions Witnesses During Senate Judiciary Committee Hearing on Supreme Court Ethics ReformПодробнее

Durbin Questions Witnesses During Judiciary Subcommittee Hearing on Supreme Court Ethics ReformПодробнее

Senate Finance Committee Hearing on Prescription Drug Price InflationПодробнее

Senate Judiciary holds hearing on prescription drug competitiveness | FULLПодробнее

The Effect of H.R. 3 on Drug Prices and Innovation — Christopher HoltПодробнее

Competition and Drug PricingПодробнее

Durbin Questions Witnesses During Immigration Subcommittee Hearing on our Health Care WorkforceПодробнее